论文部分内容阅读
西德曼海姆消息:对轻度到中度充血性心力衰竭病人的早期试验表明,增加血管紧张素转换酶(ACE)抑制剂甲巯丙脯酸,可降低死亡率和预防严重恶化,而且无明显副作用发生。慕尼黑市医院心脏病学专家Franz Kleber在此地召开的西德心血管研究协会会议上报告了上述研究结果。他进行了一项双盲、安慰剂对照试验,共78名病人。按纽约心脏协会标准,病人的心衰程度平均为2级,在原治疗方案增加25mg甲巯丙辅酸,每日2次。
Mannheim, Germany: Early trials in patients with mild to moderate congestive heart failure showed that increasing the ACE inhibitor, captopril, reduced mortality and prevented serious deterioration, and No obvious side effects occurred. Franz Kleber, Munich-based hospital cardiologist, reports the results of the study at the meeting of the West German Cardiovascular Research Association here. He conducted a double-blind, placebo-controlled trial of 78 patients. According to New York Heart Association standards, patients with an average of 2 heart failure, in the original treatment plan to increase 25mg methionine, 2 times a day.